Suchergebnisse - "CHEMOEMBOLIZATION"

Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study.

Autoren: Kim MS; Department of Nursing, Pukyong National University, Busan, South Korea. Electronic address: kanosa@pknu.ac.kr.

Quelle: European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2025 Dec; Vol. 79, pp. 103031. Date of Electronic Publication: 2025 Oct 31.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100885136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2122 (Electronic) Linking ISSN: 14623889 NLM ISO Abbreviation: Eur J Oncol Nurs Subsets: MEDLINE

MeSH-Schlagworte: Chemoembolization, Therapeutic*/adverse effects , Chemoembolization, Therapeutic*/methods , Liver Neoplasms*/therapy , Carcinoma, Hepatocellular*/therapy, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Aged ; Syndrome

Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACE.

Autoren: Lu H Liang B Zheng C et al.

Quelle: BMC gastroenterology [BMC Gastroenterol] 2025 Nov 19; Vol. 25 (1), pp. 817. Date of Electronic Publication: 2025 Nov 19.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/therapeutic use , Phenylurea Compounds*/adverse effects , Quinolines*/administration & dosage , Quinolines*/therapeutic use , Quinolines*/adverse effects , Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Treatment Outcome ; Combined Modality Therapy ; Adult

Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study.

Autoren: Zhang X Fang X Wang R et al.

Quelle: BMC cancer [BMC Cancer] 2025 Oct 31; Vol. 25 (1), pp. 1683. Date of Electronic Publication: 2025 Oct 31.

Publikationsart: Journal Article; Multicenter Study

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Pyridines*/administration & dosage, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Treatment Outcome ; Prognosis

The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery.

Autoren: Lu H Liang B Xia X et al.

Quelle: Scientific reports [Sci Rep] 2025 Oct 17; Vol. 15 (1), pp. 36426. Date of Electronic Publication: 2025 Oct 17.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/surgery , Liver Neoplasms*/therapy , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/mortality , Liver Neoplasms*/surgery , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Neoplasm Recurrence, Local*/therapy , Neoplasm Recurrence, Local*/pathology , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Pyridines*/administration & dosage , Pyridines*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Sorafenib/administration & dosage ; Sorafenib/therapeutic use ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Superselective transarterial chemoembolization (SSTACE) as second-line conversion therapy for locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma: a preliminary retrospective cohort study.

Autoren: Chen J Zhang W Wang T et al.

Quelle: European journal of medical research [Eur J Med Res] 2025 Oct 09; Vol. 30 (1), pp. 952. Date of Electronic Publication: 2025 Oct 09.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE

MeSH-Schlagworte: Stomach Neoplasms*/therapy , Stomach Neoplasms*/pathology , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Esophagogastric Junction*/pathology , Adenocarcinoma*/therapy , Adenocarcinoma*/pathology , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/pathology, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Gastrectomy ; Treatment Outcome ; Adult

Meta-analysis of the value of albumin-bilirubin grading on changes in liver function and its prognostic assessment in patients with hepatocellular carcinoma treated with transhepatic arterial chemoembolization.

Autoren: Sun X Wei T Kang T et al.

Quelle: World journal of surgical oncology [World J Surg Oncol] 2025 Oct 08; Vol. 23 (1), pp. 361. Date of Electronic Publication: 2025 Oct 08.

Publikationsart: Journal Article; Meta-Analysis

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

MeSH-Schlagworte: Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/blood , Liver Neoplasms*/mortality , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/blood , Carcinoma, Hepatocellular*/mortality , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/mortality , Bilirubin*/blood , Serum Albumin*/analysis , Serum Albumin, Human*/analysis, Humans ; Prognosis ; Survival Rate ; Liver Function Tests ; Liver/physiopathology

Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer.

Autoren: Chen Y Zang X Zhang X et al.

Quelle: Seminars in oncology [Semin Oncol] 2025 Oct; Vol. 52 (5), pp. 152393. Date of Electronic Publication: 2025 Jul 17.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8708 (Electronic) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE

MeSH-Schlagworte: Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/mortality , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Infusions, Intra-Arterial ; Adult ; Prospective Studies ; Combined Modality Therapy ; Treatment Outcome

Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial.

Autoren: Zou Y Wu SY Zhang W et al.

Quelle: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2025 Oct; Vol. 45 (10), pp. e70347.

Publikationsart: Journal Article; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Polysaccharides*/therapeutic use , Polysaccharides*/adverse effects , Polysaccharides*/administration & dosage , Antineoplastic Agents*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Aged ; Treatment Outcome ; Liver/drug effects ; Liver/physiopathology ; Liver Function Tests ; Adult

The Efficacy and Safety of TACE or HAIC Combined With ICIs and Angiogenesis Inhibitors in Unresectable Hepatocellular Carcinoma.

Autoren: Wu Q Li P Lin N et al.

Quelle: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2025 Oct 01; Vol. 48 (8), pp. 314-324. Date of Electronic Publication: 2025 Oct 01.

Publikationsart: Journal Article; Meta-Analysis

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Electronic Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

MeSH-Schlagworte: Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/drug therapy , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/administration & dosage , Immune Checkpoint Inhibitors*/adverse effects , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/drug therapy, Humans ; Combined Modality Therapy ; Infusions, Intra-Arterial ; Treatment Outcome

Association Between Discharge Medications and Oncologic Post-Embolization-Syndrome-Related Outcomes.

Autoren: Li H Moon J Sim N et al.

Quelle: Cancer medicine [Cancer Med] 2025 Dec; Vol. 14 (23), pp. e71418.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

MeSH-Schlagworte: Patient Discharge*/statistics & numerical data , Carcinoma, Hepatocellular*/therapy , Liver Neoplasms*/therapy , Chemoembolization, Therapeutic*/adverse effects , Analgesics, Opioid*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Aged ; Patient Readmission/statistics & numerical data ; Yttrium Radioisotopes/adverse effects ; Antiemetics/therapeutic use

Evolving Strategies in the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Narrative Review of Locoregional and Surgical Therapies.

Autoren: Barrera JV Bayona Molano MDP

Quelle: Techniques in vascular and interventional radiology [Tech Vasc Interv Radiol] 2025 Dec; Vol. 28 (4), pp. 101081. Date of Electronic Publication: 2025 Oct 06.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 9806675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9808 (Electronic) Linking ISSN: 15579808 NLM ISO Abbreviation: Tech Vasc Interv Radiol Subsets: MEDLINE

MeSH-Schlagworte: Portal Vein*/pathology , Portal Vein*/diagnostic imaging , Portal Vein*/surgery , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/diagnostic imaging , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology , Liver Neoplasms*/diagnostic imaging , Venous Thrombosis*/mortality , Venous Thrombosis*/therapy , Venous Thrombosis*/diagnostic imaging , Venous Thrombosis*/etiology , Venous Thrombosis*/pathology , Hepatectomy*/adverse effects , Hepatectomy*/mortality , Chemoembolization, Therapeutic*/adverse effects , Chemoembolization, Therapeutic*/mortality , Neoplastic Cells, Circulating*/pathology, Humans ; Treatment Outcome ; Risk Factors

Efficacy of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors (TKIs) in advanced hepatocellular carcinoma: a comparison with transarterial chemoembolization combined with TKIs.

Autoren: Fan L Wang L

Quelle: Acta radiologica (Stockholm, Sweden : 1987) [Acta Radiol] 2025 Dec; Vol. 66 (12), pp. 1311-1318. Date of Electronic Publication: 2025 Sep 02.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Sage Country of Publication: England NLM ID: 8706123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0455 (Electronic) Linking ISSN: 02841851 NLM ISO Abbreviation: Acta Radiol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Chemoembolization, Therapeutic*/methods , Protein Kinase Inhibitors*/administration & dosage , Protein Kinase Inhibitors*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Infusions, Intra-Arterial ; Hepatic Artery ; Aged ; Treatment Outcome ; Combined Modality Therapy ; Adult ; Antineoplastic Agents/administration & dosage ; Tyrosine Kinase Inhibitors

Pathological response after degradable starch microspheres transarterial chemoembolization for hepatocellular carcinoma: a Histopathological study on explanted livers.

Autoren: Collettini F Gottschalk H Auer TA et al.

Quelle: European journal of radiology [Eur J Radiol] 2025 Dec; Vol. 193, pp. 112454. Date of Electronic Publication: 2025 Sep 25.

Publikationsart: Journal Article; Multicenter Study

Info zur Zeitschrift: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/therapy , Chemoembolization, Therapeutic*/methods , Starch*/administration & dosage, Humans ; Male ; Female ; Aged ; Retrospective Studies ; Middle Aged ; Liver Transplantation ; Treatment Outcome ; Microspheres ; Liver/pathology ; Adult

Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT.

Autoren: Ueshima K Tsuchiya K Yamashita T et al.

Quelle: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2025 Dec; Vol. 45 (12), pp. e70379.

Publikationsart: Journal Article; Clinical Trial, Phase II

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Bevacizumab*/administration & dosage , Bevacizumab*/adverse effects , Bevacizumab*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Chemoembolization, Therapeutic* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Progression-Free Survival ; Neoplasm Staging ; Response Evaluation Criteria in Solid Tumors ; Adult

PERI-START: a phase II trial of perioperative TACE, tislelizumab, and lenvatinib in early-stage hepatocellular carcinoma.

Autoren: Kong D Tang Y Zhou Y et al.

Quelle: Future oncology (London, England) [Future Oncol] 2025 Dec; Vol. 21 (28), pp. 3611-3617. Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article; Clinical Trial Protocol

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

MeSH-Schlagworte: Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/mortality , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/mortality , Quinolines*/administration & dosage , Quinolines*/adverse effects , Quinolines*/therapeutic use , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/adverse effects , Phenylurea Compounds*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Chemoembolization, Therapeutic*/methods , Chemoembolization, Therapeutic*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Neoplasm Staging ; Prospective Studies ; Clinical Trials, Phase II as Topic ; Neoadjuvant Therapy ; Treatment Outcome ; Female ; Male ; Hepatectomy ; Combined Modality Therapy ; Protein Kinase Inhibitors/administration & dosage

Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study.

Autoren: Zhou L Zheng L Zhang K et al.

Quelle: European journal of radiology [Eur J Radiol] 2025 Dec; Vol. 193, pp. 112442. Date of Electronic Publication: 2025 Sep 20.

Publikationsart: Journal Article; Multicenter Study

Info zur Zeitschrift: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/diagnostic imaging , Carcinoma, Hepatocellular*/therapy , Liver Neoplasms*/diagnostic imaging , Liver Neoplasms*/therapy , Chemoembolization, Therapeutic*/methods , Neoplasm Recurrence, Local*/diagnostic imaging , Magnetic Resonance Imaging*/methods, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Nomograms ; Radiomics

Radiofrequency ablation with or without conventional transarterial chemoembolization for subcapsular versus nonsubcapsular hepatocellular carcinoma within Milan criteria: a propensity score-matched study.

Autoren: Guan H Xie Y Lyu T et al.

Quelle: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2025 Dec; Vol. 42 (1), pp. 2452930. Date of Electronic Publication: 2025 Feb 26.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Chemoembolization, Therapeutic*/methods , Radiofrequency Ablation*/methods, Humans ; Female ; Male ; Propensity Score ; Middle Aged ; Aged ; Retrospective Studies

Unresectable ectopic hepatocellular carcinoma in the left sub-diaphragmatic area and retroperitoneum treated with TACE: case report and literature review.

Autoren: Xie CB Tang ZJ Wu Y et al.

Quelle: Cancer biology & therapy [Cancer Biol Ther] 2025 Dec; Vol. 26 (1), pp. 2510029. Date of Electronic Publication: 2025 Jun 21.

Publikationsart: Journal Article; Case Reports; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/diagnosis , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/diagnosis , Chemoembolization, Therapeutic*/methods, Humans ; Male ; Middle Aged

CT-Based Habitat Model for Predicting Tumor Response and Survival in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors.

Autoren: Shen X Zhang JX Yan HT et al.

Quelle: Academic radiology [Acad Radiol] 2025 Dec; Vol. 32 (12), pp. 7095-7107. Date of Electronic Publication: 2025 Oct 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/diagnostic imaging , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/therapy , Liver Neoplasms*/diagnostic imaging , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology , Chemoembolization, Therapeutic*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Tomography, X-Ray Computed*/methods , Molecular Targeted Therapy*, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Treatment Outcome ; Combined Modality Therapy

Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma.

Autoren: Guo ZY Tu MY Yang YS et al.

Quelle: Scientific reports [Sci Rep] 2025 Nov 27; Vol. 15 (1), pp. 42367. Date of Electronic Publication: 2025 Nov 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/virology , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/virology , Liver Neoplasms*/pathology , Nomograms* , Chemoembolization, Therapeutic*/methods , Neoplasm Recurrence, Local*/mortality , Hepatitis B*/complications, Humans ; Male ; Female ; Middle Aged ; Hepatitis B virus ; Aged ; Adult ; Prognosis